Sodium aurothiomalate

DB09276ApprovedWithdrawnSmall moleculeAntirheumatic AgentsGold Compounds

Sodium aurothiomalate is a disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis. Sodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects.

Chemical structure of Sodium aurothiomalate
Mechanism
Curator reviewed
Primary indication
A disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis.Curator reviewed · 4 structured indications
Formula / weight
C4H3AuNa2O4S · 390.07 g/mol (avg)
First approval
Canada, 2005
Also known as
Gold sodium thiomalate

Resolves to

Compound
UNIIHRS6S09A0HCAS12244-57-4ChEBI35864PubChem16760302
Clinical / RWD
RxNorm4981ATCM01CB01
Structure
InChIKeyVXIHRIQNJCRFQX-UHFFFAOYSA-KSMILES[Na+].[Na+].[O-]C(=O)CC(S[Au])C([O-])=O
Targets
P41743PRKCI

What you can answer from here — as of September 14, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
815Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
8ContraindicationsEach with its own population and attribute set
Sign in
9Marketed productsAcross 4 countries and 5 labellers
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Sodium aurothiomalate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In